Showing 6291-6300 of 8699 results for "".
- Skin Cancer Foundation Champions for Change Gala Coming in Octoberhttps://practicaldermatology.com/news/skin-cancer-foundation-champions-for-change-gala-coming-in-october/2460142/The Skin Cancer Foundation’s annual Champions for Change Gala comes to The Plaza New York City October 17. The Champions for Change Gala is the signature fundraising event for The Skin Cancer Foundation’s programs and initiatives. Awards a
- Innovations In Skin Of Color Dermatology Award Presented to Dr. Andrew F. Alexishttps://practicaldermatology.com/news/innovations-in-skin-of-color-dermatology-award-presented-to-dr-andrew-f-alexis/2460140/The Journal of Drugs in Dermatology (JDD) presented dermatologist Andrew F. Alexis, MD, MPH, with the Innovations in Skin of Color Dermatology Award at Skin of Color Update, formerly Skin of Color Seminar Series, held September 7 and 8 in New York. The award recognizes individuals who ha
- DermTech Closes Combination with Constellation Alpha Capital Corphttps://practicaldermatology.com/news/dermtech-closes-combination-with-constellation-alpha-capital-corp/2460138/DermTech, Inc., a precision dermatology company enabled by a non-invasive skin genomics platform, has completed its previously announced business combination with Constellation Alpha Capital Corp., a publicly traded special purpose acquisition company prior to the business combination. As a resul
- FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannulahttps://practicaldermatology.com/news/fda-approves-juvederm-voluma-xc-for-mid-face-injection-via-cannula/2460137/Allergan’s Juvéderm Voluma XC is now U.S. Food and Drug Administration (FDA)-approved for cheek augmentation in the mid-face in adults over 21 with a TSK Steriglide cannula. This cannula features a patented tip design with a near-tip delivery port for precise product p
- ACS Study: Skin Creams Aren’t What We Thought They Werehttps://practicaldermatology.com/news/acs-study-skin-creams-arent-what-we-thought-they-were/2460136/Researchers report the first direct glimpse of how a skin cream or lotion is structured on the molecular scale, and it’s not quite what they expected. They presented their results at the American Chemical Society (ACS) Fall 2019 National Meeting & Exposition in San Diego.
- ASDS 2018 Survey: Skin Cancer Treatments and Cosmetic Procedures are on the Risehttps://practicaldermatology.com/news/asds-2018-survey-skin-cancer-treatments-and-cosmetic-procedures-are-on-the-rise/2460133/American Society for Dermatologic Surgery (ASDS) member dermatologists performed more than 12.5 million medical and cosmetic procedures in 2018 – 7.5 percent more than 2017 and a 60 percent increase since 2012, according to the 2018 ASDS
- Europe Grants DefenAge Skincare Master Patenthttps://practicaldermatology.com/news/europe-grants-defenage-skincare-master-patent/2460132/DefenAge Skincare now has a master patent from the European Patent Office that covers DefenAge’s core technology. The patent protects the exclusive rights of DefenAge to use the spectrum of immune peptides called defensins in topical cosmetic formulations in a specific range of co
- Blocking LSD1 May Thwart Common Skin Cancer Growthhttps://practicaldermatology.com/news/blocking-lsd1-may-thwart-common-skin-cancer-growth/2460130/The outer layer of the skin completely replaces itself every two to four weeks, but when this process is blocked, cancer can grow. A new study from researchers in the Perelman School of Medicine at the University of Pennsylvania has now identifie
- Why Don't More Derms Use Lab-based Tools to ID Fungal Infections?https://practicaldermatology.com/news/why-dont-more-derms-use-lab-based-tools-to-id-fungal-infections/2460128/Fungal diagnostic preparations can assist the accurate diagnosis of cutaneous fungal infections. A survey from a team at the George Washington University (GW) identifies barriers that prevent their consistent use. The study is published in the
- Soliton Treats First Patients in Cellulite Trialhttps://practicaldermatology.com/news/soliton-treats-first-patients-in-cellulite-trial/2460124/The first patients in Soliton’s cellulite trial have been treated, the Company reports. "Patient treatments have now begun at the Chicago site,” says Dr. Chris Capelli, President, CEO and co-founder of Soliton, in a ne